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Abstract
Body mass index (BMI) and waist circumference (WC) are two common anthropometric measures 
of obesity in clinical and public health practice. Consensus, however, remains elusive regarding 
their utility for predicting cardiovascular disease risk in multiethnic populations. We address this 
gap in the literature by analyzing cross-sectional data from the first round of the Los Angeles 
County Health and Nutrition Examination Survey, 2011. We characterized the relationships 
between BMI, WC, waist-to-hip ratios, waist-to-height ratios, and chronic disease extent, as 
confirmed by the presence of hypertension, diabetes, and/or two or more other chronic conditions 
as defined by a composite indicator ‘comorbidity’. To account for race/ethnicity, age, gender, and 
cigarette smoking frequency, adjusted odds ratios (aOR) were generated and reported for each of 
the regression analyses. Whereas being overweight was associated with hypertension alone (aOR 
2.10; 95% CI 1.12–3.94), obesity was associated with hypertension (aOR 5.04; 95% CI 2.80–9.06) 
as well as diabetes (aOR 5.28; 95% CI 2.25–12.3) and comorbidity (aOR 3.69; 95% CI 2.02–
6.77). In whites and African-Americans, BMI and WC were positively related to diabetes, 
hypertension and comorbidity. In Hispanics, BMI and WC were also positively related to diabetes 
and comorbidity, but only the former measure was associated with hypertension (p<0.050). In 
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Asians, BMI was not a significant predictor of diabetes, hypertension and/or comorbidity. 
Collectively, the findings suggest that BMI is not universally informative and waist circumference 
and its derivatives may represent a viable, more racially/ethnically appropriate alternative for use 
with selected minority groups.
Keywords
anthropometry; race/ethnicity; obesity; diabetes; hypertension; health disparities
Introduction
Body mass index (BMI) is a commonly used anthropometric proxy for obesity in 
epidemiologic studies, given the ease of using height and weight, which can be self-reported 
by participants during telephone or in-person interviews. Body composition categories have 
been established by the World Health Organization (WHO), using BMI cut-off points – 
underweight, normal weight, overweight, and obese. BMI, however, is not an accurate 
measure of body composition since the weight contribution of muscle, fat and bone cannot 
be fully disentangled. BMI also does not provide information on the distribution of weight 
across the body, which is often of greater interest in evaluating cardiovascular disease 
(CVD) risk. Previously published studies have focused on sex differences in anthropometric 
measures as risk factors for CVD [1, 2]. The risk profiles for men and women are influenced 
by percentages of visceral versus subcutaneous fat deposits, reflecting the importance of 
visceral adipose tissue in the etiology of CVD. As a result, measures of visceral adiposity 
such as waist circumference (WC) and waist-to-hip ratio (WHR) have emerged as the 
preferred anthropometric measures for ascertaining risk across sex [3–6]. Use of waist-to-
height ratio (WHtR) by researchers has also increased recently, particularly in stratifying 
risk by sex and in intra-category stratification of normal and overweight BMI [7].
The utility of an anthropometric measure as a predictor of CVD and CVD risk factors is 
dependent on race as well as sex. Several published studies have examined the 
appropriateness of specific anthropometric measures as risk factors for CVD in different 
racial groups [8–17]. Although relatively meticulous in their analysis, these studies were 
largely conducted outside of the United States (U.S.) and in geographic regions where race, 
diet, and environmental exposures are homogeneous within the country in which the study 
originated. Only a handful of studies of anthropometry, race, and CVD have been conducted 
in the U.S. in racially heterogeneous populations that shared dietary and environmental 
exposures [18]. Zhu et al., for example, used cross-sectional NHANES III data and found 
WC to be a more sensitive indicator of CVD in a multiethnic sample of whites, African-
Americans, and Mexican-Americans [19]. Another study by Lutsey and colleagues 
examined data from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort and observed 
that race modifies the effect of BMI and WC on incident diabetes [20].
In this cross-sectional study, we used primary data from the 2011 Los Angeles County 
Health and Nutritional Examination Survey (LA HANES) to examine the association of 
anthropometric measures and CVD risk factors in a multiethnic population in Los Angeles, 
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California. We hypothesize that race/ethnicity will modify the utility of anthropometric 
measures as predictors of prevalent diabetes, hypertension and/or other chronic disease 
comorbidities.
Methods
Study Population
The first round of the LA HANES is a population-based, cross-sectional survey of adult 
residents of Los Angeles County. LA HANES participants were sampled from participants 
in the 2010–11 Los Angeles County Health Survey (LACHS) (n=4926) and from a random 
probability sample of visitors to public health clinics in Los Angeles County (n=1393).
Approximately 22% and 53% of the 2010–11 LACHS participants indicated a willingness to 
participate in either the LA HANES (n=1067) or a future survey (n=2612), respectively, for 
a total of 3679 individuals (Figure 1). A call list was generated based on LACHS 
participants willing to participate and with valid names (n=1506). LA HANES participants 
were recruited by phone from the LACHS call list between February–May 2011 to either an 
appointment with an interviewer at a public health center (n=339) or as an in-home 
appointment with an interviewer (n=34). Of those clinic visitors that were probability 
sampled between March–April 2011, approximately 71% agreed to an appointment with an 
interviewer at a public health center and 726 of the 983 appointments were kept.
During the in-public health center and in-home interviews, a total of 947 participants 
completed the LA HANES epidemiologic survey that included questions pertaining to socio-
demographic characteristics, tobacco smoking, physical activity, diet and eating behaviors, 
chronic conditions, and medications. Trained LA HANES staff also collected 
anthropometric measurements, blood pressure, and urine samples at the time of survey. 
Pregnant women were excluded from survey participation. All study protocols and materials 
were reviewed and approved by the Los Angeles County Department of Public Health 
Institutional Review Board (IRB#2010-12-302, approved January 2011) prior to fieldwork. 
Written consent was obtained from all LA HANES participants prior to data and specimen 
collection.
Anthropometric and Blood Pressure Measures
Height (in), weight (lbs), waist circumference (cm), hip circumference (cm), and blood 
pressure were measured in duplicate by trained LA HANES staff at designated public health 
centers or at the participant’s home between January 1–March 1, 2011. Height was 
measured using a stadiometer (Seca 213, seca Precision for health, United Kingdom) and 
weight was measured using a digital scale (Seca 876, seca Precision for health, United 
Kingdom). Waist and hip circumference were taken using a tape measure. Systolic and 
diastolic blood pressures were measured for each participant by trained staff using a manual 
or digital blood pressure sphyngomanometer. BMI was calculated using the standard 
formula: weight (lb)/[height (in)]2 × 703. BMI cut-off points for categories were determined 
according to WHO criteria for underweight (less than 18.5 kg/m2), normal (between 18.5–
24.9 kg/m2), overweight (between 25.0–29.9 kg/m2), and obese (≥30.0 kg/m2). Blood 
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pressure (systolic, diastolic, combined) readings were classified as normal (systolic <120 
mm Hg and diastolic <80 mm Hg); suggestive of prehypertension (systolic 120–139 mm Hg 
or diastolic 80–89 mm Hg); or in stage 1 (systolic 140–159 mm Hg or diastolic 90–99 mm 
Hg) and stage 2 (systolic 160 mm Hg or diastolic 100 mm Hg) range, based on guidelines 
from the Seventh Report of the Joint National Committee on Prevention, Detection, 
Evaluation and Treatment of High Blood Pressure (JNC 7) [21]. Waist circumference (WC), 
waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR) were all dichotomized into two 
CVD risk categories: low CVD risk (WC, men <102cm, women <88cm; WHR, men <0.95, 
women <0.88; WHtR, <0.5) and high CVD risk (WC, men 102cm, women 88cm; WHR, 
men 0.95, women 0.88; WHtr, 0.5) [22].
Statistical Analysis
LA HANES participants who self-reported a physician-diagnosed chronic disease (diabetes, 
asthma, chronic obstructive pulmonary disease [COPD], heart disease, arthritis, liver 
disease, hypertension, kidney disease, and/or cancer) were included in the analysis as 
prevalent chronic disease cases (n=368). Participants who self-reported absences of 
physician-diagnosed chronic disease were included in the analysis as non-cases (n=569). 
Participants who did not provide an answer for the questions on physician-diagnosed disease 
were excluded from the analysis (n=10). A composite indicator, ‘comorbidity’, was created 
and defined as self-reported presence of at least two physician-diagnosed chronic diseases, 
excluding diabetes and hypertension. An analysis of variance (ANOVA) was performed to 
test the hypothesis that anthropometric variables (continuous measures for BMI, WC, WHR, 
WHtR) do not vary across racial/ethnic groups. Multivariable logistic regression analyses 
were conducted to examine the potential association between categories of anthropometric 
measurements (BMI, WC, WHR, WHtR) and chronic disease. Adjusted odds ratios (aOR), 
which account for race/ethnicity (white, African-American, Hispanic/Latino, Asian/Pacific 
Islander), age (Centers for Disease Control & Prevention categories of 18–24, 25–34, 35–44, 
45–54, 55–64, 65–74, 75–84, 85+ years), sex (male [men], female [women]), and cigarette 
smoking frequency (0 per day, <1, 1–5, 6–10, 11–20, 20+), were generated via these 
analyses. A chi-squared analysis was additionally performed to examine the potential 
association between anthropometric measures (categorical measures of BMI, WC) and case/
non-case status, across racial/ethnic groups. In order to assess the potential influence of 
smoking status, categories of BMI and WC by sex were compared for smokers versus non-
smokers. Parallel comparisons using a t-test were also carried out for BMI and WC as 
continuous measures. All analyses were conducted using the SAS version 9 statistical 
package (SAS Institute, Inc., Cary, North Carolina).
Results
Characteristics
The combined prevalent chronic disease case/non-case sample (Table 1) was largely women 
(58%) and either African-American (36%) or Hispanic (34%). The cases were, on average, 
10 years older than non-cases (46.4 years compared to 35.1 years, respectively) and 
predominantly African-American. Cases also differed from non-cases across all 
anthropometric variables, but were similar for smoking status. Hypertension, asthma, 
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arthritis, and diabetes were the most prevalent chronic diseases reported and 16% of the 
cases were classified as having met the other chronic disease comorbidity classification. The 
characteristics of the 937 cases and non-cases included in the study did not differ 
significantly from the overall LA HANES participant pool (n=947) by sex (58% female 
[women]), race/ethnicity (35% African-American, 34% Hispanic), or by age.
Anthropometry and CVD Risk Factors
Anthropometric measures varied by race/ethnicity (Table 2). African-Americans had higher 
BMI and WC measurements when compared to whites and Asians, and similar BMI and 
WC measurements when compared to Hispanics. African-Americans, whites and Asians 
were similar across waist-to-hip and waist-to-height ratios, with the larger waist-to-hip and 
waist-to-height ratios observed among Hispanics. BMI, WC, waist-to-hip ratio, and waist-
to-height ratio were positively associated with prevalent CVD risk factors (Table 3). Being 
overweight (BMI between 25.0–29.9 kg/m2) was associated with hypertension (aOR 2.10; 
95% CI 1.12–3.94). A positive association was suggested for being overweight and having 
diabetes (aOR 2.07; 95% CI 0.80–5.31) or comorbidity (aOR 1.66; 95% CI 0.86–3.21), but 
the association was not statistically significant. Obesity (BMI ≥ 30 kg/m2) was associated 
with diabetes (aOR 5.28; 95% CI 2.25–12.3), hypertension (aOR 5.04; 95% CI 2.80–9.06), 
and comorbidity (aOR 3.69; 95% CI 2.02–6.77). A high risk WC and high risk waist-to-hip 
ratio were positively associated with diabetes, hypertension, and comorbidity in both men 
and women. Having a high risk waist-to-height ratio was positively associated with all CVD 
risk factors.
Central Adiposity, Race/Ethnicity, and Chronic Disease
BMI and WC correlated positively with prevalent diabetes, hypertension and comorbidity in 
whites and African-Americans (Table 4). For Hispanics, BMI and WC both related 
positively with diabetes and comorbidity; however, BMI is the more prominent predictor of 
hypertension. Among Asians, BMI is not strongly related to prevalent diabetes, hypertension 
and comorbidity, but WC is for all three conditions.
Central Adiposity and Tobacco Smoking
The relationship between BMI and smoking status was not modified by sex; however, sex 
did modify the relationship between WC and smoking status (Table 5). There was no 
observed difference in the WC of women who currently smoke in comparison with women 
who are either former or never smokers. There was a significant difference for men, with 
current smokers having a waist circumference that is 3 cm, on average, larger than men who 
never or were former smokers (p<0.05).
Discussion
Visceral adiposity is an established risk factor for CVD; yet, few studies have examined 
anthropometric measures as proxies for visceral adiposity and their association with CVD 
risk factors in multiethnic populations. In this study, we observed positive associations 
between anthropometric measures and CVD risk factors in the multiethnic LA HANES 
population (sample). Our findings are consistent with previously published reports of 
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positive relationships between body mass and visceral adiposity and a higher prevalence of 
chronic disease. Our findings suggest that WC is a more reliable predictor of diabetes across 
the different racial groups in Los Angeles County. We did not observe an appreciable 
difference across racial groups in the utility of these measures of visceral adiposity (waist 
circumference, waist to hip ratio) versus BMI in predicting hypertension or other chronic 
disease comorbidity.
Waist circumference appears to be of greater utility in predicting CVD risk factors in 
Asians. Previously published studies have acknowledged that BMI categories established by 
the WHO are not ideal for Asian populations [23, 24]. Consistent with the evidence base, 
our study found that BMI categories were also not particularly useful in Asians, given the 
low prevalence of BMI-defined obesity in Asian populations [25–28]. In a longitudinal 
study of incident diabetes in a multiethnic American population, Asian participants had 
lower BMIs but experienced a steeper increase in risk as BMI and visceral adiposity 
increased as compared to other racial groups [20]. This finding supports clinical 
observations that Asians at high risk of CVD are often overlooked in obesity screening 
because of a thin-fat phenotype. Given naturally thin body frames, Asians naturally fall into 
this phenotype category, in part as a result of experiencing increases in visceral fat 
deposition, but without a corresponding increase in BMI [29]. Thus, the thin-fat phenotype 
is a key consideration when assessing Asians for CVD/obesity risk [26].
Limitations
Similar to other studies of this kind, there are several limitations worth noting. First, the LA 
HANES is a cross-sectional study using primarily self-reported variables. However, for the 
key CVD outcomes – blood pressure (hypertension), BMI, and WC – these study variables 
were objectively measured at each interview. Second, although we might expect the 
prevalent chronic disease cases (survey participants) to modify their diet, exercise, and 
smoking habits since disease diagnosis, this potential bias is likely to result in an 
underestimate of the association between anthropometry and CVD risk factors. This would 
attenuate rather than accentuate our findings toward the null. Finally, the size of the LA 
HANES sample limits our study in that we were unable to fully stratify on race/ethnicity, 
sex, and chronic disease. However, given that the LA HANES was administered a second 
time during 2012, there is the possibility of a future pooled analysis stratified on these 
variables. This more comprehensive analysis would help strengthen the external validity of 
the LA HANES source population.
Conclusions
Our present analysis of the first round of the LA HANES reinforces the need for more race/
ethnicity appropriate measures of obesity and CVD risk. Our findings support the inclusion 
of waist circumference as a routine measurement in research studies and clinical practice, 
especially in regions with multiethnic populations. Despite the increased costs of measuring 
and adding waist circumference to obesity/CVD risk assessments, attaining better accuracy 
and population health profiles that are more comprehensive should lead to better designs and 
tailoring of health and public health interventions in the community. Future research are 
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clearly needed to further delineate the utility of these anthropometric measures (WC, WHR, 
WHtR) in clinical and public health practice, especially with respect to health risk 
assessments of minority groups in which BMI is not an optimal indicator of obesity and 
downstream CVD risk.
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Figure 1. 
Phone Recruitment of Participants from the 2010–11 Los Angeles County Health Survey, 
February–April 2011.
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